MELBOURNE ENT released its interim results, with a loss attributable to shareholders of HKD 142 million, turning from profit to loss year-on-year
According to the Zhitong Finance APP, MELBOURNE ENT released its unaudited interim results for the six months ended March 31, 2025, with revenue of HKD 81.947 million, an increase of 2.58% year-on-year; the loss attributable to shareholders was HKD 142 million, compared to a profit attributable to shareholders of HKD 18.961 million in the same period last year, resulting in a year-on-year loss; the basic loss per share was HKD 5.66
According to the Zhitong Finance APP, MELBOURNE ENT (00158) released its unaudited interim results for the six months ended March 31, 2025, with revenue of HKD 81.947 million, an increase of 2.58% year-on-year; the loss attributable to shareholders was HKD 142 million, compared to a profit attributable to shareholders of HKD 18.961 million in the same period last year, marking a year-on-year turnaround from profit to loss; the basic loss per share was HKD 5.66
